Código QR

Metformin as an adjuvant option for systemic treatment of breast cancer

The modification of the used and development of new treatment regimens significantly improved the overall, recurrence-free survival and quality of life of patients with malignant oncological diseases. Recently, drugs used in non-oncological pathology have been introduced into cancer treatment regim...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: D.I. Avierin, V.F. Zavizion
Formato: Artigo
Idioma:Inglês
Publicado: Dnipro State Medical University 2023-12-01
Series:Medičnì Perspektivi
Assuntos:
Acceso en liña:https://journals.uran.ua/index.php/2307-0404/article/view/294154
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!